Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial-Reference-Cited by-同舟云学术

Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial

Published:2006-08 Issue:5 Volume:65 Page:1471-1478
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Mornex Françoise,Girard Nicolas,Scoazec Jean-Yves,Bossard Nadine,Ychou Marc,Smith Denis,Seitz Jean-François,Valette Pierre-Jean,Roy Pascal,Rouanet Philippe,Ducreux Michel,Partensky Christian

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands;Bramhall;Br J Surg,1985

2. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience;Yeo;Ann Surg,1997

3. Further evidence of effective adjuvant combined radiation and chemotherapy after curative resection of pancreatic cancer;Cancer,1987

4. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region;Klinkenbijl;Ann Surg,1999

5. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas;Spitz;J Clin Oncol,1997

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Cisplatin-Containing Chemotherapy Regimens in Patients of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis;Journal of Gastrointestinal Cancer;2024-02-05

2. Advances in the management of pancreatic cancer;BMJ;2023-12-13

3. Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis;World Journal of Gastrointestinal Oncology;2022-10-15

4. Defining the Optimal Duration of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma;Pancreas;2022-10

5. Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer;Management of Pancreatic Cancer and Cholangiocarcinoma;2021